Sir, Selenium is an essential oligo-element for the human body, obtained from food of vegetable or animal origin. Its average consumption differs significantly among countries, and in Brazil, the recommended dietary allowance is 34 mcg/day for adults. [1] Reference values for serum selenium concentration are controversial and range approximately from 46 to 143 mcg/L. Most part of the selenium ingested is absorbed in the duodenum and then converted by the liver in selenocysteine, an amino acid used in the biosynthesis of selenoproteins, enzymes with antioxidant properties. [2] Moreover, selenium seems to prevent the production of immunosuppressive cytokines, thus increasing both cellular and humoral immunity. [3] Accordingly, a few systematic reviews have associated adequate selenium levels to the prevention of some types of cancer, cardiovascular, and autoimmune diseases. Nevertheless, other studies did not show any benefits of selenium supplements, suggesting they may even lead to numerous side effects including nonscarring alopecias. Selenosis may occur when selenium's daily intake is higher than 400 mcg. In this case, arthralgia, fatigue, headache, nausea, vomiting, diarrhea and telogen effluvium have been reported. There are no known antidotes for the intoxication, but high serum levels reverse from 6 weeks of suspending the ingestion.
Studies in murine models have demonstrated that about 10-15 selenoproteins exist in the skin and that their depletion leads to the development of hyperplastic epidermis and aberrant morphogenesis of hair follicles. Some mice submitted to selenium-restrictive diet developed poliosis and mild telogen effluvium, while an intense telogen effluvium was observed in those with excessive selenium. A regular diet caused no clinical abnormalities. Selenium levels imbalance could function as a triggering factor for an organic oxidative stress, inducing mitochondrial membrane apoptosis, which leads to hair cycle impairment and telogen effluvium. [4] It has also been reported that newborns on parenteral nutrition with too little selenium developed delayed growth, dyschromias such as pseudoalbinism and telogen effluvium more often; all of them reversible with adequate supplementation.
An Iranian study has compared patients with several degrees of alopecia areata to a control group and observed significantly lower serum selenium levels in the first group
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The Relevance of Selenium to Alopecias though there was no statistical difference among cases. [5] In our own records, 40 patients with alopecia areata were evaluated with serum selenium dosage, and there was no statistically significant difference between them and a control group.
Nowadays, when miraculously promising diets and supplements containing selenium are many times taken indiscriminately, selenosis must be remembered in case of telogen effluvium with fatigue, diarrhea, arthralgia, headache, and nausea. Hyperselenemia can also be found in refractory effluviums while hyposelenemia may be present in total parenteral nutrition or short-bowel syndrome patients. On the other hand, there is no consistent data to sustain the association between alopecia areata and serum selenium levels. Therefore, physicians need to share their experiences and data, focusing on better criteria for requesting selenium tests, thus reducing unnecessary expenses and treatments based exclusively on laboratory values.
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patients should be further followed up to look for any signs of vitiligo. In addition, frontal area was involved in majority (40%) of the patients. The onset of graying of scalp hairs varies according to gender. In majority of our male patients, occiput (36.4%) and frontal (34%) area were first to be involved whereas, in females, it was more commonly in the frontal area (44.6%) [ Figure 1 ].
Autoimmune thyroid disease has been found to be associated with premature graying. [1, 5] In our study, thyroid profile was deranged in 14% of the patients (mean thyroid-stimulating hormone level of 1.99 ± 1 mIU/L), out of which 13% had hypothyroidism [ Table 2 ]. Due to lack of availability, antithyroid antibody profile of the patients Sir, Premature graying of hair is a condition whose exact etiology, and treatment is still considered as inconclusive. Multiple factors such as genetics, environmental factors, autoimmune disorders (such as pernicious anemia, hyper-or hypo-thyroidism), oxidative stress, nutritional deficiencies, and malabsorption, drugs are said to be implicated in the etiopathogenesis of premature graying. [1] [2] [3] [4] We conducted this cross-sectional, observational study to understand the clinical pattern, underlying micronutrient deficiencies, and endocrine abnormalities in 100 patients of premature graying. All patients with onset of hair graying before 25 years of age were recruited in the study. After taking informed consent, a detailed clinical history and laboratory investigations (including complete blood count, iron studies, thyroid function test, and serum Vitamin B12 levels) were done.
In our study, we have found that the incidence of graying was similar in men and women (n = 44 and n = 56, respectively). The age of patients ranged from 2 to 28 years, with mean age of onset of graying 15.1 ± 5.2 years. Nearly 29% of the patients gave positive family history of premature graying. It was surprising to find that none of our patients had vitiligo despite the fact that family history of vitiligo in first-degree relatives was present in 15% of our study patients [ Table 1 ]. We suggest that premature graying can be an initial presentation, and these 
